17-Cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6beta-[(2'-indolyl)acetamido]morphinan

ID: ALA3319610

Chembl Id: CHEMBL3319610

PubChem CID: 102340665

Max Phase: Preclinical

Molecular Formula: C29H31N3O4

Molecular Weight: 485.58

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C(N[C@@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5)c1cc2ccccc2[nH]1

Standard InChI:  InChI=1S/C29H31N3O4/c33-22-8-7-18-14-23-29(35)10-9-20(31-27(34)21-13-17-3-1-2-4-19(17)30-21)26-28(29,24(18)25(22)36-26)11-12-32(23)15-16-5-6-16/h1-4,7-8,13,16,20,23,26,30,33,35H,5-6,9-12,14-15H2,(H,31,34)/t20-,23-,26+,28+,29-/m1/s1

Standard InChI Key:  FANZOSRNSKEJDL-XSGLBDKUSA-N

Alternative Forms

1. Parent:

   

   ALA3319610

   N-2'-Indolylnaltrexamine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 485.58

Molecular Weight (Monoisotopic): 485.2315

AlogP: 3.24

#Rotatable Bonds: 4

Polar Surface Area: 97.82

Molecular Species: BASE

HBA: 5

HBD: 4

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 4

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.29

CX Basic pKa: 9.50

CX LogP: 2.39

CX LogD: 0.57

Aromatic Rings: 3

Heavy Atoms: 36

QED Weighted: 0.46

Np Likeness Score: 0.70

References

1. Le Naour M, Lunzer MM, Powers MD, Kalyuzhny AE, Benneyworth MA, Thomas MJ, Portoghese PS..  (2014)  Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects.,  57  (15): [PMID:24978316] [10.1021/jm500159d]

Source

Source(1):

• Scientific Literature